Author:
Nevzglyadova O. V.,Artemov A. V.,Zenin V. V.,Verkhusha V. V.,Shavlovsky M. M.,Povarova O. I.,Stepanenko O. V.,Kuznetsova I. M.,Turoverov K. K.
Reference36 articles.
1. Aspenstrom, P., Engkvist, H., Lindberg, U., and Karlsson, R., Characterization of Yeast-expressed Beta-actins, Site-specifically Mutated at the Tumor-related Residue Gly245, Eur. J. Biochem., 1992, vol. 207, pp. 315–320.
2. Bailleul-Winslett, P.A., Newnam, G.P., Steenbergen, J.N., and Chernoff, Y.O., Genetic Study of Interaction between the Cytoskeletal Assembly Protein Sla1 and Prion-forming Domain of the Release Factor Sup35 (eRF3) in Saccharomyces cerevisiae, Genetics, 1999, vol. 153, pp. 81–94.
3. Bailleul-Winslett, P.A., Newnam, G.P., Wegrzyn, R.D., and Chernoff, Y.O., An Antiprion Effect of the Anticytoskeletal Drug Latrunculin A in Yeast, Gene Express., 2000, vol. 9, pp. 145–156.
4. Bertazzon, A., Tian, G.H., Lamblin, A., and Tsong, T.Y., Enthalpic and Entropic Contributions to Actin Stability: Calorimetry, Circular Dichroism and Fluorescence Study and Effect of Calcium, Biochemistry, 1990, vol. 29, pp. 291–298.
5. Bunch, T.A., Grinblat, Y., and Goldstein, L.S., Characterization and Use of the Drosophila metallothionein Promoter in Cultured Drosophila melanogaster Cells, Nucleic Acids Res., 1988, vol. 16, pp. 1043–1061.